Product
Standard CDI
1 clinical trial
2 indications
Indication
Clostridium difficile infectionClinical trial
Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile InfectionStatus: Completed, Estimated PCD: 2023-02-22
1 clinical trial
2 indications